TRYVIO
Active substance: aprocitentan
CAPSULE · APROCITENTAN 12.5 mg/1
United StatesActive
Marketing holder: Excella GmbH & Co. KG
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 2
Composition
- APROCITENTAN · 12.5 mg/1
Analogues by country
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| EU 1 |
|
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a12093-3c42-7b3e-be6d-e2e071eaaac3,01a1209a-17d5-72a8-bd78-f7a97b4f1ed3;count=2 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 46014-8012
- Registration status
- Active
- Dispensing
- Prescription only
Sources
- product · openFDA NDC · 46014-8012 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 46014-8012 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 46014-8012 · Verified 2026-10-09 · open in source